1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. REVELATION BIOSCIENCES INC
Revelation Biosciences Inc
XNAS: REVB
Download real time
1.07 -0.01 (-0.93%)
97.33% Fall from 52W High
48,277
XNAS Volume

XNAS 05 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Revelation Biosciences Inc

The latest disclosure was made by Chester S. Zygmont in Revelation Biosciences Inc where a trade of 13,285 Common Stock done at an average price of $1.1 was reported to US exchanges on April 30, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Chester S. Zygmont Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. 30 Apr 2026 13,285 92,063 - 1.1 14,614 Common Stock
James Rolke Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 30 Apr 2026 10,115 214,738 - 1.1 11,430 Common Stock
Chester S. Zygmont Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.65 per share. 04 Feb 2026 13,100 105,348 - 1.7 21,615 Common Stock
Jennifer A. Carver Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. 03 Feb 2026 1,661 12,758 - 1.9 3,106 Common Stock
Lakhmir S. Chawla Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.85 per share. 03 Feb 2026 2,261 12,158 - 1.9 4,183 Common Stock
James Rolke Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. 03 Feb 2026 8,521 224,853 - 1.9 15,849 Common Stock
Jess Roper Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.85 per share. 03 Feb 2026 1,591 12,828 - 1.8 2,943 Common Stock
Lakhmir S. Chawla Director Grant, award, or other acquisition of securities at price $ 0.90 per share. 08 Jan 2026 41,981 57,667 - 0.9 37,783 Common Stock
Jess Roper Director Grant, award, or other acquisition of securities at price $ 0.90 per share. 08 Jan 2026 41,981 57,667 - 0.9 37,783 Common Stock
James Rolke Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.90 per share. 08 Jan 2026 532,829 933,489 - 0.9 479,546 Common Stock
Chester S. Zygmont Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.90 per share. 08 Jan 2026 78,145 473,790 - 0.9 70,331 Common Stock
Jennifer A. Carver Director Grant, award, or other acquisition of securities at price $ 0.90 per share. 08 Jan 2026 41,981 57,669 - 0.9 37,783 Common Stock
Jennifer A. Carver Director Grant, award, or other acquisition of securities at price $ 1.28 per share. 29 Oct 2025 15,625 15,688 - 1.3 20,000 Common Stock
Lakhmir S. Chawla Director Grant, award, or other acquisition of securities at price $ 1.28 per share. 29 Oct 2025 15,625 15,686 - 1.3 20,000 Common Stock
Chester S. Zygmont Chief Financial Officer Grant, award, or other acquisition of securities at price $ 1.28 per share. 29 Oct 2025 390,614 395,645 - 1.3 499,986 Common Stock
James Rolke Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.28 per share. 29 Oct 2025 390,614 400,660 - 1.3 499,986 Common Stock
Jess Roper Director Grant, award, or other acquisition of securities at price $ 1.28 per share. 29 Oct 2025 15,625 15,686 - 1.3 20,000 Common Stock
Lakhmir S. Chawla Director Grant, award, or other acquisition of securities at price $ 3.87 per share. 11 Feb 2025 181 181 - 3.9 700 Common Stock
Jennifer A. Carver Director Grant, award, or other acquisition of securities at price $ 3.87 per share. 11 Feb 2025 181 187 - 3.9 700 Common Stock
S. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.87 per share. 11 Feb 2025 15,048 15,076 - 3.9 58,236 Common Stock
James Rolke Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 3.87 per share. 11 Feb 2025 30,095 30,137 - 3.9 116,468 Common Stock
Jess Roper Director Grant, award, or other acquisition of securities at price $ 3.87 per share. 11 Feb 2025 181 183 - 3.9 700 Common Stock
George F. Tidmarsh Director Grant, award, or other acquisition of securities at price $ 3.87 per share. 11 Feb 2025 181 268 - 3.9 700 Common Stock
F. George Tidmarsh Director 08 Dec 2023 27,771 0 - 0.5 14,438 Common Stock
George F. Tidmarsh Director 17 Apr 2023 26,500 39,848 - 1.2 30,740 Common Stock
George F. Tidmarsh Director 17 Apr 2023 25,000 64,848 - 1.2 29,000 Common Stock
Jennifer A. Carver Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 6,356 6,356 - - Stock Option (Right to Buy)
George F. Tidmarsh Director 14 Apr 2023 6,356 6,356 - - Stock Option (Right to Buy)
Jess Roper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 6,356 6,356 - - Stock Option (Right to Buy)
Curt H. LaBelle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 6,356 6,356 - - Stock Option (Right to Buy)
James Rolke Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2023 2,542 0 - - Stock Option (Right to Buy)
Chester Zygmont Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2023 611 0 - - Stock Option (Right to Buy)
George F. Tidmarsh Director, Ten Percent Owner 25 Feb 2022 20,000 467,156 - 1.6 32,000 Common Stock
George F. Tidmarsh Director, Ten Percent Owner 08 Feb 2022 30,000 447,156 - 2.6 76,599 Common Stock
George F. Tidmarsh Director, Ten Percent Owner 08 Feb 2022 1,000 417,156 - 2.5 2,540 Common Stock
George F. Tidmarsh Director, Ten Percent Owner 04 Feb 2022 7,900 1,481,235 - 2.3 18,256 Common Stock
George F. Tidmarsh Director, Ten Percent Owner 04 Feb 2022 2,000 416,156 - 2.5 4,900 Common Stock
George F. Tidmarsh Director, Ten Percent Owner 04 Feb 2022 42,100 1,523,335 - 2.6 109,780 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters